Nutriband announced the appointment of Sergei Glinka to its board of directors.Glinka, an Estonian citizen, is a businessman who has held numerous Executive and Board positions in large European Companies providing Glinka with deep insights and networks across various industries in Europe. Currently Mr. Glinka serves on the Boards of European Companies including Automecanica Skb Property Srl., GST Investments OU and TG Biochemicals Ltd. As the seventh member of Nutriband’s board of directors, Glinka is poised to facilitate new licensing and networking opportunities throughout Europe as Nutriband aims to expand its groundbreaking AVERSA technology internationally. Currently, AVERSA is patented in 45 countries, including all EU countries and the UK. Glinka invested $4.5M in Nutriband through the Company’s $8.4M private placement announced in April 2024. Nutriband believes these funds are sufficient to complete the FDA-approval process for its AVERSA technology.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTRB:
- Nutriband closes $8.4M private placement for development of Aversa patch
- Nutriband signs exclusive supplier agreement with Fit for Life Group
- Nutriband to sell 2.1M shares at $4.00 in private placement
- Nutriband begins manufacturing for Fit For Life Group
- Nutriband presents data on incidence of transdermal patch abuse